AGENDA

Architecting a

Pro-Innovation Ecosystem

for Latin America

MAIN PAGE

Architecting a Pro-Innovation Ecosystem for Latin America

MAIN PAGE

OCTOBER 28TH, 2025

Museo Casa del Risco | Plaza de San Jacinto 5 y 15, San Ángel. Alcaldía Álvaro Obregón. Ciudad de México 01000

08:40 – 09:10

Registration

09:10 – 09:20

Opening Ceremony

09:10 – 09:20

Opening Ceremony

SPEAKER:

Andrew Jenner, Director
General – Interpat (UK)

09:25 – 10:25

PANEL 1

09:25 – 10:25

PANEL 1

SPEAKERS:

Anjam Aziz, PhRMA, Senior Director, International Advocacy – Intellectual Property (USA)
Jon Santamauro, Senior Director, International Government Affairs, AbbVie (USA)
Alejandro Luna, Presidente del consejo directivo – AMPPI (Asociación Mexicana para la Protección de la Propiedad Intelectual)

MODERATOR:

Xavier Rosales, Partner – Corral Rosales

The Geopolitical Landscape of IP:
Navigating Global Trade Dynamics and Life Science Innovation in LATAM

CONTENT:

The panel will discuss how global trade, U.S. influence, and geopolitical shifts shape Latin America’s IP ecosystem, highlighting their effects on economic security, investment, and policy balance, while exploring future regional challenges and opportunities.

10:30 – 11:00

Coffee Break

11:05 – 12:05

PANEL 2

11:05 – 12:05

PANEL 2

SPEAKERS:

Gonzalo Rovira, Head of Intellectual Property & Licensing, Latin America – Bayer
Mariela Mege, Head of Legal Department of the Chilean Public Health Institute
Diego Ortega, Technical Secretary at the Commission of Inventions and New Technologies – INDECOPI
Marianela Beltrán, Head of Patents & Trademarks LatAm Grünenthal

MODERATOR:

Maritza Reátuegui, Senior Partner, Chair Life Sciences – Rodrigo, Elias & Medrano Abogados

Subsequent Patient-Centric Innovation in LATAM

CONTENT:

The panel will highlight the value of iterative R&D in improving therapeutic options for patients and strengthening health systems. It will address patentability criteria for subsequent inventions, such as new formulations or methods of use, and feature case studies from biopharmaceutical and technology sectors showcasing real benefits for patients and consumers.

12:05 – 14:05

Lunch Break

14:10 – 15:10

PANEL 3

14:10 – 15:10

PANEL 3

SPEAKERS:

Fernando Portugal, Director of Intellectual Property, Legal and International Affair, AMIIF
Bettina Wanner, Patent Attorney, Bayer
Ernesto Manríquez, Head of the Patent Examination Department – INAPI
Dr. Alexandre Dantas Rodrigues, INPI

MODERATOR:

Karla Olvera, Senior Associate attorney at the litigation department – OLIVARES

Strengthening the Core IP Ecosystem in LATAM

CONTENT:

The panel will examine strategies to optimize Patent Linkage and Patent Term Adjustment (PTA) systems, focusing on how to protect innovation while maintaining transparency. It will explore the role of Regulatory Data Protection (RDP) as a distinct incentive for R&D investment in both small molecules and biologics, and discuss mechanisms and justifications for PTA as a tool to compensate for administrative and regulatory delays.

15:15 – 15:45

Coffee Break

15:50 – 16:50

PANEL 4

15:50 – 16:50

PANEL 4

SPEAKERS:

Gustavo Fischer, Partner – FISCHER Abogados, Technology, Innovation & Intellectual Property
Raquel Sorza, Health Policy Director – Fifarma
Carlos Felipe Escobar, Director HUB IEX, Univesidad El Bosque
Ignacio Gilmore, Partner at Carey

MODERATOR:

Ana Castro, Partner, Lloreda Camacho

Compulsory Licensing and Public Health in LATAM

CONTENT:

The panel will explore the legal frameworks and recent applications of compulsory licensing across key jurisdictions, using the COVID-19 pandemic as a case study on access to health technologies during crises. It will analyze compulsory licensing as a tool in pricing and market access negotiations, while also examining alternative models to ensure equitable access in future public health emergencies.

18:00 – 20:00

Cocktail

Olivares | Pedro Luis Ogazón 17, Col. San Ángel, 01000, Ciudad de México.

OCTOBER 29TH, 2025

Museo Casa del Risco | Plaza de San Jacinto 5 y 15, San Ángel. Alcaldía Álvaro Obregón. Ciudad de México 01000

09:00 – 09:40

Round table:

Shaping a pro-innovation ecosystem for Latin America.

SPEAKERS:

Maritza Reategui, Senior Partner, Chair Life Sciences – Rodrigo, Elias & Medrano Abogados
Ignácio Gilmore, Partner – Carey
Ana Castro, Partner – Lloreda Camacho
Ingrid Ortiz – UNAM

MODERATOR:

Hugo Carrasco – UNAM

09:40 – 09:50

Updates on US IP Programs

SPEAKERS:

Claudia Rojas, Senior Legal Specialist for Intellectual Property – U.S. Embassy Mexico City

CONTENT:

Stay informed about the latest developments in U.S. Intellectual Property programs. This session brings together experts to discuss recent regulatory changes, new guidelines, and emerging trends shaping innovation and IP protection.

09:50 – 11:05

PANEL 5

SPEAKERS:

Corey Salsberg, Vice President, Global Head IP Affairs, Novartis
Benjamín Castañeda, Professor at the University of Rochester
Pablo Pruneda Gross – UNAM (awating confirmation)

MODERATOR:

Cristian Bittel, Partner – Marval, O’Farrell & Mairal

The Role of AI in the R&D Pipeline

CONTENT:

The panel will discuss how artificial intelligence is transforming discovery and development processes, accelerating innovation across sectors. It will examine whether current IP frameworks are sufficient to protect AI-driven inventions and address emerging legal and policy challenges related to inventorship, ownership, and data in an increasingly AI-powered world.

11:05 – 11:20

Coffee Break

11:25 – 12:25

PANEL 6

SPEAKERS:

Judge Gonzalo Auguste (Argentina)
Judge Ximena Velastigui (Ecuador)
Judge Francisco Medina Padilla (Mexico)
Judge César Chaparro (Colombia)

MODERATOR:

Carlos Olarte, Partner – OlarteMoure

Relevant Jurisprudence on Patent-Related Issues in LATAM

CONTENT:

The panel will provide insights from the judiciary on key IP issues affecting biopharmaceutical innovation. It will examine how courts are ruling on pivotal cases, discuss the presumption of patent validity in enforcement actions, and highlight the judiciary’s role in ensuring legal certainty and a stable environment for innovators.